Peripheral Artery Disease: Past, Present, and Future - 06/11/19
, Marie Gerhard-Herman, MD a, b, Gregory Piazza, MD a, b, Samuel Z. Goldhaber, MD a, bAbstract |
Peripheral artery disease is a prevalent but underdiagnosed manifestation of atherosclerosis. There is insufficient awareness of its clinical manifestations, including intermittent claudication and critical limb ischemia and of its risk of adverse cardiovascular and limb outcomes. In addition, our inadequate knowledge of its pathophysiology has also limited the development of effective treatments, particularly in the presence of critical limb ischemia. This review aims to highlight essential elements of the epidemiology and pathophysiology of peripheral artery disease, bring attention to the often-atypical manifestations of occlusive arterial disease of the lower extremity, increase awareness of critical limb ischemia, briefly describe the diagnostic role of the ankle brachial index, and go over the contemporary management of peripheral artery disease. An emphasis is placed on evidence-based medical treatments to improve symptoms and quality of life and to reduce the risk of cardiovascular and limb events in these patients, including supervised exercise training, smoking cessation, antagonism of the renin-angiotensin system, lipid-lowering, antiplatelet, and antithrombotic therapies.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiovascular risk, Critical limb ischemia, Intermittent claudication, Peripheral artery disease
Plan
| Funding: None. |
|
| Conflicts of Interest: UC and MGH, none. GP receives grant and research support from BMS, Daiichi-Sankyo, BTG, Janssen, Bayer, and Portola and is on the advisory panel for Pfizer. SZG receives research support from Boehringer-Ingelheim, BMS, BTG EKOS, Daiichi, Janssen, NHLBI, and Thrombosis Research Institute and is a consultant for Bayer; Boehringer-Ingelheim; BMS; Daiichi; Janssen; Portola. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. UC conceived, drafted, designed figures, and had final approval of the manuscript. MGH, GP, and SZG revised and had final approval of the manuscript. |
Vol 132 - N° 10
P. 1133-1141 - octobre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
